Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial †

Background: Low-molecular-weight fucoidan (LMF) is widely used as a food supplement for cancer patients. However, all of the studies are in vitro or were conducted using mice. Therefore, powerful clinical evidence for LMF use is relatively weak. This study aimed to evaluate the efficacy of LMF as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiang-Lin, Tai, Chi-Jung, Huang, Ching-Wen, Chang, Fang-Rong, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408268/
https://www.ncbi.nlm.nih.gov/pubmed/28430159
http://dx.doi.org/10.3390/md15040122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408268/
https://www.ncbi.nlm.nih.gov/pubmed/28430159
http://dx.doi.org/10.3390/md15040122

Ejemplares similares